Literature DB >> 1372248

Domain structure of the human immunodeficiency virus reverse transcriptase.

H Lederer1, O Schatz, R May, H Crespi, J L Darlix, S F Le Grice, H Heumann.   

Abstract

The spatial arrangement of subunits p51 and p66 of the HIV-1 reverse transcriptase and the position of the RNase H containing domain, p15, have been determined by means of neutron small-angle scattering. The reverse transcriptase (p66/p51) is a flat molecule, which can be approximated by an ellipsoid with the half axes of 5.2 nm, 4.8 nm and 1.4 nm. The two subunits p51 and p66 having a centre-to-centre distance of 3.3 +/- 0.3 nm are attached at their flat sides, slightly shifted sideways. The p15 domain is located at the long axis of the ellipsoidal reverse transcriptase having a distance of 5.0 +/- 0.5 nm to the centre of the p51d domain, which is part of the p66 subunit, and a distance of 5.3 +/- 1.2 nm to the centre of the neighbouring p51s subunit.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372248      PMCID: PMC556555          DOI: 10.1002/j.1460-2075.1992.tb05153.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  33 in total

1.  Dimerization of human immunodeficiency virus type 1 reverse transcriptase. A target for chemotherapeutic intervention.

Authors:  T Restle; B Müller; R S Goody
Journal:  J Biol Chem       Date:  1990-06-05       Impact factor: 5.157

2.  Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants.

Authors:  A Hizi; C McGill; S H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

Review 3.  Reverse transcription.

Authors:  H Varmus
Journal:  Sci Am       Date:  1987-09       Impact factor: 2.142

4.  Contrast variation study of specifically deuterated Escherichia coli ribosomal subunits.

Authors:  R R Crichton; D M Engleman; J Haas; M H Koch; P B Moore; R Parfait; H B Stuhrmann
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

5.  Structure of ribonuclease H phased at 2 A resolution by MAD analysis of the selenomethionyl protein.

Authors:  W Yang; W A Hendrickson; R J Crouch; Y Satow
Journal:  Science       Date:  1990-09-21       Impact factor: 47.728

6.  A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site.

Authors:  J C Wu; T C Warren; J Adams; J Proudfoot; J Skiles; P Raghavan; C Perry; I Potocki; P R Farina; P M Grob
Journal:  Biochemistry       Date:  1991-02-26       Impact factor: 3.162

7.  Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor.

Authors:  V J Merluzzi; K D Hargrave; M Labadia; K Grozinger; M Skoog; J C Wu; C K Shih; K Eckner; S Hattox; J Adams
Journal:  Science       Date:  1990-12-07       Impact factor: 47.728

8.  Interaction of HIV-1 ribonuclease H with polypurine tract containing RNA-DNA hybrids.

Authors:  B M Wöhrl; K Moelling
Journal:  Biochemistry       Date:  1990-11-06       Impact factor: 3.162

9.  Deuterium incorporation into Escherichia coli proteins. A neutron-scattering study of DNA-dependent RNA polymerase.

Authors:  H Lederer; R P May; J K Kjems; W Schaefer; H L Crespi; H Heumann
Journal:  Eur J Biochem       Date:  1986-05-02

10.  Subunit-selective mutagenesis indicates minimal polymerase activity in heterodimer-associated p51 HIV-1 reverse transcriptase.

Authors:  S F Le Grice; T Naas; B Wohlgensinger; O Schatz
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  3 in total

Review 1.  Multimodal Functionalities of HIV-1 Integrase.

Authors:  Alan N Engelman; Mamuka Kvaratskhelia
Journal:  Viruses       Date:  2022-04-28       Impact factor: 5.818

2.  Hydroxyl radical footprint analysis of human immunodeficiency virus reverse transcriptase-template.primer complexes.

Authors:  W Metzger; T Hermann; O Schatz; S F Le Grice; H Heumann
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

3.  Comparative evaluation of the inhibitory activities of a series of pyrimidinedione congeners that inhibit human immunodeficiency virus types 1 and 2.

Authors:  Robert W Buckheit; Tracy L Hartman; Karen M Watson; Sun-Gan Chung; Eui-Hwan Cho
Journal:  Antimicrob Agents Chemother       Date:  2007-10-29       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.